s-spider oligopeptide-1 hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

s-spider oligopeptide-1 hamilelikte güvenli mi?

No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).

s-spider oligopeptide-1 emzirirken güvenli mi?

No regulatory or peer-reviewed evidence of reproductive or lactation-specific hazards for oligopeptide-1/EGF. As a peptide with low systemic absorption from topical use, there is no demonstrated mechanism or data indicating transfer into breast milk or lactation-related effects in mother or infant. Sources: CIR/SCCS databases (no adverse findings), PubMed (no lactation transfer data indicating hazard), CosIng.

s-spider oligopeptide-1 bebek cildi için güvenli mi?

Hazard and mechanism: no evidence of developmental or reproductive toxicity specific to infants. Exposure: while adult dermal absorption is expected to be negligible for a large peptide (adult e=0), infant skin has higher surface-area-to-weight and an immature barrier so exposure is plausibly higher; therefore exposure score increased by +1 to e=1 for 0–3 yr skin. No infant-specific adverse data were identified in PubMed or regulatory sources. Sources: PubMed (no infant toxicity reports), CosIng, ECHA (no harmonised classification).

VeriMom s-spider oligopeptide-1 nasıl puanlıyor?

VeriMom s-spider oligopeptide-1'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte s-spider oligopeptide-1 yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.